Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Salvage therapy with combined cyclophosphamide ( C ), fludarabine (F), alemtuzumab (A), and rituximab (R) (CFAR) for heavily pre-treated patients with CLL
The most common side effects are gastrointestinal, including nausea, vomiting, diarrhoea, and abdominal discomfort, which are usually mild
Fact vs
By addressing the root causes of obesity, this treatment empowers individuals to achieve long-term health improvements, boost confidence, and reduce the risk of life-threatening conditions
US$ 23.05
US$ 24.89
US$ 26.20
US$ 21.34
US$ 25.03
US$ 29.90
